Following is a listing of executive and legislative action for the week of July 11. Members of the House of Representatives are scheduled to return to Harrisburg on Sept. 19; Senate members on Sept. 26.

Signed Into Law

• Gov. Tom Wolf signed HB 60, sponsored by Rep. Matt Baker, R-Tioga, which will require insurance companies to provide coverage for oral anti-cancer medications on the same level they do for intravenous treatments. Baker said HB 60, now Act 37 of 2016, addresses the cost disparity between intravenous and oral anti-cancer treatments. Previously, intravenous anti-cancer medications were covered under a health plan’s medical benefit, often only requiring patients to pay a minimal fixed co-payment; however, oral anti-cancer medications were covered under a health plan’s pharmacy benefit, and required patients to pay a percentage of the total cost of the drug, generally between 25 and 30 percent. With the average cost for a one-month supply of an oral anti-cancer medication costing $7,000, some cancer patients in Pennsylvania were left with a co-insurance cost of between $1,400 and $3,500 per month.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]